Havva Kocayi̇ğİt
Havva Kocayi̇ğİt has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ali Fuat Erdem
Department of Anesthesiology and Reanimation, Faculty of Medicine, Sakarya University, Sakarya, Turkiye
1 shared publication - Gürkan Demir
Sakarya University Faculty of Medicine
1 shared publication İbRahim Kocayi̇ğİt
1 shared publication- Kezban Özmen Süner
Department of Intensive Care, Sakarya University Training and Research Hospital, Sakarya, Türkiye
1 shared publication - Mehmet Halil Öztürk
Sakarya University, Adapazarı, Turkey
1 shared publication - Mehmet Köroğlu
Department of Medical Microbiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey
1 shared publication
Latest Publications
- Open Access
- 30 April 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (2) , 440-447
Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Turkey on March 10, 2020 and the number of the patients are increasing day by day. Coronavirus disease 2019 (Covid-19) has high mortality rates in the intensive care unit (ICU). We aimed to describe the demographic characteristics, co-morbidities, treatment protocols and clinical outcomes among the critically ill patients admitted to ICU of our hospital. This cohort study included 103 consecutive patients who was laboratory confirmed Covid-19 and admitted to ICU of XXXXX Hospital between March 19 and April 13, 2020. The final date of the follow-up was April 18. The mean age of the patients was 69.6±14.1 years. Most of the patients had increased CRP (99%), serum ferritin (73.8%), D-dimer (82.5%) and hs-troponin levels (38.8%). 34 patients (33%) had lymphocytopenia, 24 patients (23.3%) had thrombocytopenia. 63 patients (61.2%) developed ARDS, 31 patients (30.1%) had acute kidney injury and 52 patients (50.5%) had MODS during follow-up. 62 patients (60.2%) received mechanical ventilation. As of April 18, of the 103 patients, 52 (50.5%) had died, 30 (29.1%) had been discharged from the ICU, 21 (20.4%) were still in the ICU. Covid-19 has high mortality rates in ICU. Patients with elevated procalcitonin, hs-troponin, d-dimer and CRP levels and lower platelet count at admission has higher mortality.
- 30 April 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (2) , 440-447
Open AccessCharacteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Turkey on March 10, 2020 and the number of the patients are increasing day by day. Coronavirus disease 2019 (Covid-19) has high mortality rates in the intensive care unit (ICU). We aimed to describe the demographic characteristics, co-morbidities, treatment protocols and clinical outcomes among the critically ill patients admitted to ICU of our hospital. This cohort study included 103 consecutive patients who was laboratory confirmed Covid-19 and admitted to ICU of XXXXX Hospital between March 19 and April 13, 2020. The final date of the follow-up was April 18. The mean age of the patients was 69.6±14.1 years. Most of the patients had increased CRP (99%), serum ferritin (73.8%), D-dimer (82.5%) and hs-troponin levels (38.8%). 34 patients (33%) had lymphocytopenia, 24 patients (23.3%) had thrombocytopenia. 63 patients (61.2%) developed ARDS, 31 patients (30.1%) had acute kidney injury and 52 patients (50.5%) had MODS during follow-up. 62 patients (60.2%) received mechanical ventilation. As of April 18, of the 103 patients, 52 (50.5%) had died, 30 (29.1%) had been discharged from the ICU, 21 (20.4%) were still in the ICU. Covid-19 has high mortality rates in ICU. Patients with elevated procalcitonin, hs-troponin, d-dimer and CRP levels and lower platelet count at admission has higher mortality.